Drug profile · INN
dofetilide
TIKOSYN
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
dofetilide (TIKOSYN) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN dofetilide
Brand TIKOSYN
Route ORAL
Formulation CAPSULE
ATC code C01BD04
Originator Teva Pharma GmbH
Related patents
Search patents →Frequently asked questions
What is dofetilide?
dofetilide (TIKOSYN) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dofetilide?
TIKOSYN is a marketed brand name for dofetilide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dofetilide?
dofetilide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.